By Inteledoc Expert Team | 10 min read | Dr. Naveen Satija, MBBS, FIAGES, DNB (Surgery)
There is a category of weight loss difficulty that every commercial diet and selfdirected programme is almost entirely unequipped to handle. It is the weight that does not move despite genuine effort — not because the person is not trying, but because an underlying medical condition is silently and powerfully working against every attempt. PCOD. Thyroid dysfunction. Insulin resistance. Fatty liver. Chronic cortisol elevation. These conditions are not rare in India. They are extremely common. And a doctor prescribed weight loss programme addresses them in ways that nothing else can.
The Conditions Most Commonly Sabotaging Indian Weight Loss Attempts
Understanding the specific conditions that make weight loss difficult — and how they operate biologically — is the first step to understanding why a doctor prescribed approach is not just preferable but necessary for a large proportion of people who struggle.
PCOD — The Hormonal-Metabolic Barrier
Polycystic Ovary Disorder affects an estimated 10–20% of Indian women of reproductive age — making it one of the most prevalent conditions in the country. Its impact on weight is profound and specific. PCOD drives insulin resistance, which keeps the body locked in a nearpermanent fat-storage orientation. It elevates androgens (male hormones), which promote abdominal fat accumulation. And it disrupts the hormonal signalling involved in hunger and satiety regulation.
The result is that a woman with PCOD following the exact same diet as a woman without PCOD will typically lose significantly less weight — or none at all. Not because she is less disciplined. Because her biology is operating on a completely different hormonal substrate. A doctor prescribed programme that directly addresses insulin resistance through medical intervention, dietary strategy, and where appropriate GLP-1 treatment can produce results in PCOD patients that no standard diet approach comes close to matching. See how Inteledoc handles PCOD in our FAQ.
Hypothyroidism — The Metabolic Rate Suppressor
The thyroid gland regulates metabolic rate across every cell in the body. Underfunction — even subclinical underfunction that falls within the standard reference range but is suboptimal for the individual — can reduce resting metabolic rate measurably. The result is a person who maintains weight on caloric intake that would produce weight loss in a person with normal thyroid function, and loses weight very slowly even on significant restriction.
Standard blood tests often miss subclinical thyroid issues because the reference ranges are population-based rather than individual-specific. A doctor who understands thyroid physiology in the context of weight management looks beyond the TSH value to free T3 and free T4 levels, symptoms, and the full clinical picture. Optimising thyroid function before applying dietary restriction can transform results that were previously impossible to achieve.
Insulin Resistance — The Fat-Storage Lock
Insulin resistance — estimated to affect up to 25% of urban Indian adults — is the metabolicstate in which cells have reduced sensitivity to insulin. The pancreas compensates by producing more and more insulin. Chronically elevated insulin directly suppresses fat cell mobilisation — meaning that even during a caloric deficit, fat cells receive a constant biological signal not to release their contents. Fat burning is biochemically impaired.
Breaking insulin resistance through the right dietary approach — managing carbohydrate quality rather than just quantity, increasing protein, prioritising fibre — combined with appropriate clinical support including GLP-1 treatment where indicated, can unlock fat burning capacity that has been unavailable for years. This is not achievable through willpower or generic dieting. It requires targeted medical management.
Cortisol Excess — The Stress-Driven Storage Problem
Chronic stress — a near-universal feature of Gurugram and urban Indian professional life — produces persistent cortisol elevation. Cortisol directly promotes abdominal fat storage, increases appetite specifically for calorie-dense foods, impairs sleep quality (which further elevates cortisol the next day), and reduces the effectiveness of any dietary intervention running underneath it. Managing cortisol is not a soft lifestyle recommendation in a doctor prescribed programme. It is a clinical intervention with specific protocols and measurable effects on the weight loss outcome.
How a Doctor Prescribed Programme Handles Each of These
All four conditions are identified through the comprehensive metabolic blood panel that begins every Inteledoc programme — not assumed or guessed based on symptoms. The specific findings determine the specific intervention.
A diet plan for someone with significant insulin resistance looks different from one for someone with hypothyroidism and adequate insulin sensitivity. A plan for PCOD includes specific protein targets and carbohydrate management strategies that differ from a general weight loss diet. Personalisation is not an add-on. It is the foundation.
GLP-1 medicines address insulin resistance and hunger dysregulation directly. Thyroid management may require dedicated treatment. Stress and cortisol protocols are integrated into the programme architecture. Each condition gets its appropriate clinical response — not a generic diet applied on top of an unaddressed biological problem.
Progress is tracked not just through weight but through the specific markers relevant to each condition — insulin levels, thyroid function, HbA1c, inflammatory markers. When these markers improve, the programme adapts. When they do not, the programme investigates why.
Frequently Asked Questions
Yes. “Normal” thyroid on a standard TSH test does not rule out suboptimal thyroid function in the context of weight management. Inteledoc’s panel includes free T3 and free T4 alongside TSH, and your doctor interprets values in the context of your complete clinical picture — not just against a population reference range. Subclinical thyroid dysfunction is commonly identified in patients who have been told their thyroid is “fine.”
Targeted fat loss from specific body areas is not directly achievable through exercise — but abdominal fat is specifically driven by insulin resistance and cortisol elevation, both of which a doctor prescribed programme addresses directly. As these hormonal drivers are corrected, abdominal fat tends to reduce preferentially — which is one reason patients in well-designed programmes often notice disproportionate improvement in waist measurement relative to overall weight loss.
Weight management support during the pre-conception period is clinically appropriate and often beneficial — particularly for women with PCOD, where weight loss can restore ovulation. GLP-1 medicines are contraindicated during pregnancy and must be stopped before conception. Your Inteledoc doctor will manage this transition carefully, providing dietary and lifestyle support that can continue safely through pregnancy planning.
Yes — a family history of type 2 diabetes is a significant risk factor for insulin resistance and metabolic dysfunction, and is specifically factored into the initial assessment. For patients with strong family history, screening for pre-diabetes and insulin resistance is particularly important, and the programme is designed to address metabolic risk prevention as well as weight loss.
Yes — medication-induced weight gain is a recognised clinical challenge, and managing it requires both dietary strategy and potentially clinical support including GLP-1 treatment where appropriate. Your Inteledoc doctor will review your full medication list and design a programme that accounts for the metabolic effects of your current prescriptions.
Fatty liver (NAFLD) is typically identified through liver function blood tests and confirmed through ultrasound if indicated. The programme response involves specific dietary management — reducing fructose and refined carbohydrates, increasing protein and fibre — alongside weight loss, which is the most effective treatment for NAFLD available. GLP-1 medicines also show direct liver fat reduction benefits beyond their weight loss effects.
PCOD-related weight loss typically takes longer to initiate than weight loss in patients without insulin resistance — which is a key reason why the first few weeks of a doctor prescribed programme focus on metabolic and hormonal correction before expecting rapid scale movement. Most PCOD patients begin to see meaningful progress within eight to twelve weeks of a properly designed programme, with results continuing to improve over subsequent months.
An endocrinologist manages the endocrine condition — the thyroid issue, the PCOD, the diabetes. Inteledoc specifically integrates the management of these conditions into a comprehensive weight loss programme — addressing both the condition and the weight simultaneously, with tools including GLP-1 treatment, personalised nutrition, and metabolic monitoring designed to work together. The scope is integrated in a way that pure endocrinology management typically is not.
Ready to start your doctor-supervised weight loss journey?
Inteledoc — India's first metabolonomics-based weight loss programme. Online & in-person in Gurugram. Plans from ₹1,500/month.
Book a consultation